Crescent Capital BDC, Inc. (NASDAQ:CCAP) Receives Consensus Rating of “Moderate Buy” from Analysts

Crescent Capital BDC, Inc. (NASDAQ:CCAPGet Free Report) has received an average recommendation of “Moderate Buy” from the six ratings firms that are presently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a hold rating and five have issued a buy rating on the company. The average twelve-month price target among analysts that have issued ratings on the stock in the last year is $19.17.

Several equities research analysts recently weighed in on the stock. Keefe, Bruyette & Woods increased their target price on shares of Crescent Capital BDC from $19.00 to $20.00 and gave the company an “outperform” rating in a research note on Monday, November 25th. LADENBURG THALM/SH SH initiated coverage on shares of Crescent Capital BDC in a report on Monday, September 30th. They set a “buy” rating and a $20.00 price objective for the company.

Read Our Latest Research Report on CCAP

Crescent Capital BDC Stock Down 1.5 %

NASDAQ CCAP opened at $18.52 on Wednesday. The company has a debt-to-equity ratio of 1.14, a quick ratio of 1.26 and a current ratio of 1.26. The firm has a 50-day simple moving average of $19.18 and a 200 day simple moving average of $18.76. Crescent Capital BDC has a twelve month low of $15.91 and a twelve month high of $20.03. The stock has a market cap of $686.39 million, a PE ratio of 7.26 and a beta of 0.81.

Crescent Capital BDC Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Tuesday, December 31st will be paid a $0.42 dividend. The ex-dividend date is Tuesday, December 31st. This is a boost from Crescent Capital BDC’s previous quarterly dividend of $0.07. This represents a $1.68 dividend on an annualized basis and a yield of 9.07%. Crescent Capital BDC’s dividend payout ratio (DPR) is presently 65.88%.

Hedge Funds Weigh In On Crescent Capital BDC

Hedge funds and other institutional investors have recently bought and sold shares of the business. Condor Capital Management boosted its position in shares of Crescent Capital BDC by 12.4% during the second quarter. Condor Capital Management now owns 252,121 shares of the company’s stock worth $4,735,000 after purchasing an additional 27,801 shares in the last quarter. Sun Life Financial Inc. increased its stake in Crescent Capital BDC by 8.1% in the 2nd quarter. Sun Life Financial Inc. now owns 1,843,766 shares of the company’s stock valued at $34,626,000 after buying an additional 137,684 shares during the last quarter. XTX Topco Ltd acquired a new position in shares of Crescent Capital BDC during the 2nd quarter worth about $195,000. Marshall Wace LLP acquired a new position in shares of Crescent Capital BDC during the 2nd quarter worth about $767,000. Finally, Cubist Systematic Strategies LLC acquired a new position in shares of Crescent Capital BDC during the 2nd quarter worth about $346,000. 49.46% of the stock is owned by institutional investors.

About Crescent Capital BDC

(Get Free Report

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

Featured Stories

Analyst Recommendations for Crescent Capital BDC (NASDAQ:CCAP)

Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.